000 | 01840 a2200589 4500 | ||
---|---|---|---|
005 | 20250513210409.0 | ||
264 | 0 | _c20000921 | |
008 | 200009s 0 0 eng d | ||
022 | _a0953-8178 | ||
024 | 7 |
_a10.1093/intimm/12.5.631 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSolvason, N | |
245 | 0 | 0 |
_aCyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development. _h[electronic resource] |
260 |
_bInternational immunology _cMay 2000 |
||
300 |
_a631-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies _xpharmacology |
650 | 0 | 4 |
_aB-Lymphocytes _xcytology |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCD40 Antigens _xpharmacology |
650 | 0 | 4 |
_aCD5 Antigens _xanalysis |
650 | 0 | 4 | _aCell Differentiation |
650 | 0 | 4 | _aCell Division |
650 | 0 | 4 | _aCyclin D2 |
650 | 0 | 4 | _aCyclin D3 |
650 | 0 | 4 |
_aCyclins _xanalysis |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 |
_aImmunoglobulins _ximmunology |
650 | 0 | 4 |
_aInterleukin-4 _xpharmacology |
650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aOncogene Proteins _xpharmacology |
650 | 0 | 4 | _aProtein-Tyrosine Kinases |
650 | 0 | 4 | _aProto-Oncogene Proteins |
650 | 0 | 4 | _aProto-Oncogene Proteins c-bcr |
700 | 1 | _aWu, W W | |
700 | 1 | _aParry, D | |
700 | 1 | _aMahony, D | |
700 | 1 | _aLam, E W | |
700 | 1 | _aGlassford, J | |
700 | 1 | _aKlaus, G G | |
700 | 1 | _aSicinski, P | |
700 | 1 | _aWeinberg, R | |
700 | 1 | _aLiu, Y J | |
700 | 1 | _aHoward, M | |
700 | 1 | _aLees, E | |
773 | 0 |
_tInternational immunology _gvol. 12 _gno. 5 _gp. 631-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/intimm/12.5.631 _zAvailable from publisher's website |
999 |
_c10737532 _d10737532 |